Literature DB >> 15509520

Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population.

Bruce M Boman1, Rhonda Walters, Jeremy Z Fields, Albert J Kovatich, Tao Zhang, Gerald A Isenberg, Scott D Goldstein, Juan P Palazzo.   

Abstract

Familial adenomatous polyposis patients, who have a germline APC mutation, develop adenomas in normal-appearing colonic mucosa, and in the process usually acquire a mutation in the other APC allele as well. Nonetheless, the cellular mechanisms that link these initiating genetic changes with the earliest tissue changes (upward shift in the labeling index) in colon tumorigenesis are unclear. Based on the tenet that colorectal cancer originates from crypt stem cells (SCs) and on our kinetic modeling, we hypothesized that overpopulation of mutant colonic SCs is the missing link. Directly testing this hypothesis requires measuring changes in the size of the SC population, but specific markers for human colonic SCs are lacking. Hence, we used immunohistochemical mapping to study crypt base cells, of which SCs are a subset. Using colectomy specimens from 16 familial adenomatous polyposis and 11 control cases, we determined the topographic profiles of various cell populations along the crypt axis and the proportions of each cell type. In the formation of adenomatous crypts, the distribution of cells expressing crypt base cell markers (MSH2, Bcl-2, survivin) expanded toward the crypt surface and showed the greatest proportional increase (fivefold to eightfold). Cells expressing a marker for the upper crypt (p27(kip1)) shifted to the crypt bottom and showed the smallest increase. This suggests that: 1) during adenoma development, APC mutations cause expansion of the crypt base cell population, including crypt SCs; 2) SC overpopulation can explain the shifts in pattern of proliferative crypt cell populations in early colon tumorigenesis, and 3) mutant crypt SCs clonally expand to form colonic adenomas and carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509520      PMCID: PMC1618673          DOI: 10.1016/S0002-9440(10)63407-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  "Stemness": transcriptional profiling of embryonic and adult stem cells.

Authors:  Miguel Ramalho-Santos; Soonsang Yoon; Yumi Matsuzaki; Richard C Mulligan; Douglas A Melton
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

2.  In vivo measurements in familial polyposis: kinetics and location of proliferating cells in colonic adenomas.

Authors:  C Lightdale; M Lipkin; E Deschner
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

3.  Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells.

Authors:  S Y Koyama; D K Podolsky
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation.

Authors:  M Kurokowa; K Lynch; D K Podolsky
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

5.  The APC gene product in normal and tumor cells.

Authors:  K J Smith; K A Johnson; T M Bryan; D E Hill; S Markowitz; J K Willson; C Paraskeva; G M Petersen; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 6.  Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers.

Authors:  M Risio
Journal:  J Cell Biochem Suppl       Date:  1992

7.  The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.

Authors:  A Strife; C Lambek; A Perez; Z Darzynkiewicz; J Skierski; S Gulati; J D Haley; P ten Dijke; K K Iwata; B D Clarkson
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

8.  Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli.

Authors:  C S Potten; M Kellett; D A Rew; S A Roberts
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

9.  Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest.

Authors:  P H Howe; G Draetta; E B Leof
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system.

Authors:  A R Moser; W F Dove; K A Roth; J I Gordon
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  29 in total

1.  Identification of a developmental gene expression signature, including HOX genes, for the normal human colonic crypt stem cell niche: overexpression of the signature parallels stem cell overpopulation during colon tumorigenesis.

Authors:  Seema Bhatlekar; Sankar Addya; Moreh Salunek; Christopher R Orr; Saul Surrey; Steven McKenzie; Jeremy Z Fields; Bruce M Boman
Journal:  Stem Cells Dev       Date:  2013-11-05       Impact factor: 3.272

Review 2.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 3.  Mesenchymal cells of the intestinal lamina propria.

Authors:  D W Powell; I V Pinchuk; J I Saada; Xin Chen; R C Mifflin
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

4.  Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development.

Authors:  Tao Zhang; Jeremy Z Fields; Lynn Opdenaker; Tomas Otevrel; Emi Masuda; Juan P Palazzo; Gerald A Isenberg; Scott D Goldstein; Marc Brand; Bruce M Boman
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

5.  Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease.

Authors:  Heitor S P de Souza; Gail A West; Nancy Rebert; Carol de la Motte; Judy Drazba; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2012-06-26       Impact factor: 22.682

6.  Comparing a discrete and continuum model of the intestinal crypt.

Authors:  Philip J Murray; Alex Walter; Alexander G Fletcher; Carina M Edwards; Marcus J Tindall; Philip K Maini
Journal:  Phys Biol       Date:  2011-03-16       Impact factor: 2.583

7.  The role of cell proliferation and crypt fission in adenoma aggressiveness: a comparison of ileoanal pouch and rectal adenomas in familial adenomatous polyposis.

Authors:  O C C Will; M Deheragoda; R K S Phillips; S K Clark; I P M Tomlinson
Journal:  Colorectal Dis       Date:  2011-04       Impact factor: 3.788

Review 8.  Survivin as a global target of intrinsic tumor suppression networks.

Authors:  Minakshi Guha; Dario C Altieri
Journal:  Cell Cycle       Date:  2009-09-07       Impact factor: 4.534

9.  Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression.

Authors:  Li-Fang Fan; Wei-Guo Dong; Cong-Qing Jiang; Qun Qian; Qiong-Fang Yu
Journal:  Int J Colorectal Dis       Date:  2008-08-14       Impact factor: 2.571

10.  Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice.

Authors:  Guangchun Jin; Vigneshwaran Ramanathan; Michael Quante; Gwang Ho Baik; Xiangdong Yang; Sophie S W Wang; Shuiping Tu; Shanisha A K Gordon; David Mark Pritchard; Andrea Varro; Arthur Shulkes; Timothy C Wang
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.